Does first-line treatment impact the cost-effectiveness of second-line treatment for elderly metastatic colon cancer patients?

被引：0
|
作者：
Mullins, C. Daniel
Woldemichael, Andinet
Zheng, Zhiyuan
Onukwugha, Ebere
Seal, Brian S.
Hanna, Nader
机构：
[1] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Bayer HealthCare Pharmaceut, Wayne, NJ USA
[5] Univ Maryland, Dept Surg, Div Gen & Oncol Surg, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR FIRST-LINE TREATMENT IN PATIENTS WITH PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER IN THE UNITED STATES
    Monk, Bradley
    Boer, Jennifer
    Van Hees, Frank
    Van Mens, Sophie
    Swami, Shilpi
    Muston, Dominic
    Tekin, Cumhur
    Keefe, Steve
    Monberg, Matthew
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A38 - A38
  • [32] Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
    Franken, M. D.
    van Rooijen, E. M.
    May, A. M.
    Koffijberg, H.
    van Tinteren, H.
    Mol, L.
    ten Tije, A. J.
    Creemers, G. J.
    van der Velden, A. M. T.
    Tanis, B. C.
    Groot, C. A. Uyl-de
    Punt, C. J. A.
    Koopman, M.
    van Oijen, M. G. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 75 : 204 - 212
  • [33] Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer
    K. Zhou
    F. Wen
    P. Zhang
    J. Zhou
    H. Chen
    H. Zheng
    Y. Yang
    Q. Li
    [J]. Clinical and Translational Oncology, 2017, 19 : 1117 - 1124
  • [34] Efficacy and cost-effectiveness of second-line chemotherapy in elderly patients with advanced gastric cancer
    Zhou, K.
    Wen, F.
    Zhang, P.
    Zhou, J.
    Chen, H.
    Zheng, H.
    Yang, Y.
    Li, Q.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09): : 1117 - 1124
  • [35] EFFICACY AND COST-EFFECTIVENESS OF SECOND-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
    Zhou, K.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A871 - A871
  • [36] EFFICACY AND COST-EFFECTIVENESS OF SECOND-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
    Zhou, K.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A92 - A92
  • [37] Cost-effectiveness of taxanes as second line agents in treatment of metastatic breast cancer
    Kawatkar, AA
    Hay, JW
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A108 - A108
  • [38] First-Line Treatment Strategies for Elderly Patients with Metastatic Colorectal Cancer
    Hielke J. Meulenbeld
    Geert-Jan Creemers
    [J]. Drugs & Aging, 2007, 24 : 223 - 238
  • [39] First-line treatment strategies for elderly patients with metastatic colorectal cancer
    Meulenbeld, Hielke J.
    Creemers, Geert-Jan
    [J]. DRUGS & AGING, 2007, 24 (03) : 223 - 238
  • [40] FIRST-LINE MAINTENANCE AND SECOND-LINE TREATMENT OF ADVANCED OR METASTATIC GASTRIC CANCER: A SYSTEMATIC REVIEW OF LITERATURE
    Singh, B.
    Attri, S.
    Kaur, G.
    Flynn, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S421 - S421
12345